|
1
|
Walters DG, Young PJ, Agus C, Knize MG,
Boobis AR, Gooderham NJ and Lake BG: Cruciferous vegetable
consumption alters the metabolism of the dietary carcinogen
2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans.
Carcinogenesis. 25:1659–1669. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Igura K, Ohta T, Kuroda Y and Kaji K:
Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer
Lett. 171:11–16. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hertog MG and Hollman PC: Potential health
effects of the dietary flavonol quercetin. Eur J Clin Nutr.
50:63–71. 1996.PubMed/NCBI
|
|
4
|
Coskun O, Kanter M, Korkmaz A and Oter S:
Quercetin, a flavonoid antioxidant, prevents and protects
streptozotocin-induced oxidative stress and beta-cell damage in rat
pancreas. Pharmacol Res. 51:117–123. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boots AW, Wilms LC, Swennen EL, Kleinjans
JC, Bast A and Haenen GR: In vitro and ex vivo anti-inflammatory
activity of quercetin in healthy volunteers. Nutrition. 24:703–710.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Geetha T, Malhotra V, Chopra K and Kaur
IP: Antimutagenic and antioxidant/prooxidant activity of quercetin.
Indian J Exp Biol. 43:61–67. 2005.PubMed/NCBI
|
|
7
|
Sudan S and Rupasinghe HP:
Quercetin-3-O-glucoside induces human DNA topoisomerase II
inhibition, cell cycle arrest and apoptosis in hepatocellular
carcinoma cells. Anticancer Res. 34:1691–1699. 2014.PubMed/NCBI
|
|
8
|
Danihelová M, Veverka M, Sturdík E and
Jantová S: Antioxidant action and cytotoxicity on HeLa and NIH-3T3
cells of new quercetin derivatives. Interdiscip Toxicol. 6:209–216.
2013. View Article : Google Scholar
|
|
9
|
Deng XH, Song HY, Zhou YF, Yuan GY and
Zheng FJ: Effects of quercetin on the proliferation of breast
cancer cells and expression of survivin in vitro. Exp Ther Med.
6:1155–1158. 2013.PubMed/NCBI
|
|
10
|
van Erk MJ, Roepman P, van der Lende TR,
Stierum RH, Aarts JM, van Bladeren PJ and van Ommen B: Integrated
assessment by multiple gene expression analysis of quercetin
bioactivity on anticancer-related mechanisms in colon cancer cells
in vitro. Eur J Nutr. 44:143–156. 2005. View Article : Google Scholar
|
|
11
|
Murtaza I, Marra G, Schlapbach R,
Patrignani A, Künzli M, Wagner U, Sabates J and Dutt A: A
preliminary investigation demonstrating the effect of quercetin on
the expression of genes related to cell-cycle arrest, apoptosis and
xenobiotic metabolism in human CO115 colon-adenocarcinoma cells
using DNA microarray. Biotechnol Appl Biochem. 45:29–36. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Verma AK, Johnson JA, Gould MN and Tanner
MA: Inhibition of 7,12-dimethylbenz(a)anthracene- and
N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol
quercetin. Cancer Res. 48:5754–5758. 1988.PubMed/NCBI
|
|
13
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fan TJ, Han LH, Cong RS and Liang J:
Caspase family proteases and apoptosis. Acta Biochim Biophys Sin
(Shanghai). 37:719–727. 2005. View Article : Google Scholar
|
|
15
|
Bosch M, Poulter NS, Vatovec S and
Franklin-Tong VE: Initiation of programmed cell death in
self-incompatibility: Role for cytoskeleton modifications and
several caspase-like activities. Mol Plant. 1:879–887. 2008.
View Article : Google Scholar
|
|
16
|
Zhang A, Wu Y, Lai HWL and Yew DT:
Apoptosis - a brief review. Neuroembryology. 3:47–59. 2004.
View Article : Google Scholar
|
|
17
|
Waring P and Müllbacher A: Cell death
induced by the Fas/Fas ligand pathway and its role in pathology.
Immunol Cell Biol. 77:312–317. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gupta S: Molecular signaling in death
receptor and mitochondrial pathways of apoptosis (Review). Int J
Oncol. 22:15–20. 2003.
|
|
19
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boulares AH, Yakovlev AG, Ivanova V,
Stoica BA, Wang G, Iyer S and Smulson M: Role of poly(ADP-ribose)
polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP
mutant increases rates of apoptosis in transfected cells. J Biol
Chem. 274:22932–22940. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wilson CA, Cajulis EE, Green JL, Olsen TM,
Chung YA, Damore MA, Dering J, Calzone FJ and Slamon DJ: HER-2
overexpression differentially alters transforming growth
factor-beta responses in luminal versus mesenchymal human breast
cancer cells. Breast Cancer Res. 7:R1058–R1079. 2005. View Article : Google Scholar
|
|
22
|
Joshi JP, Brown NE, Griner SE and Nahta R:
Growth differentiation factor 15 (GDF15)-mediated HER2
phosphorylation reduces trastuzumab sensitivity of
HER2-overexpressing breast cancer cells. Biochem Pharmacol.
82:1090–1099. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Favoni RE, Daga A, Malatesta P and Florio
T: Preclinical studies identify novel targeted pharmacological
strategies for treatment of human malignant pleural mesothelioma.
Br J Pharmacol. 166:532–553. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tokunaga E, Oki E, Nishida K, Koga T,
Egashira A, Morita M, Kakeji Y and Maehara Y: Trastuzumab and
breast cancer: Developments and current status. Int J Clin Oncol.
11:199–208. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dean-Colomb W and Esteva FJ: Her2-positive
breast cancer: Herceptin and beyond. Eur J Cancer. 44:2806–2812.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Seo HS, Choi HS, Choi HS, Choi YK, Um JY,
Choi I, Shin YC and Ko SG: Phytoestrogens induce apoptosis via
extrinsic pathway, inhibiting nuclear factor-kappaB signaling in
HER2-overexpressing breast cancer cells. Anticancer Res.
31:3301–3313. 2011.PubMed/NCBI
|
|
27
|
Seo HS, Choi HS, Kim SR, Choi YK, Woo SM,
Shin I, Woo JK, Park SY, Shin YC and Ko SG: Apigenin induces
apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3
and NFκB signaling in HER2-overexpressing breast cancer cells. Mol
Cell Biochem. 366:319–334. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jung JE, Lee HG, Cho IH, Chung DH, Yoon
SH, Yang YM, Lee JW, Choi S, Park JW, Ye SK, et al: STAT3 is a
potential modulator of HIF-1-mediated VEGF expression in human
renal carcinoma cells. FASEB J. 19:1296–1298. 2005.PubMed/NCBI
|
|
29
|
Earnshaw WC, Martins LM and Kaufmann SH:
Mammalian caspases: Structure, activation, substrates, and
functions during apoptosis. Annu Rev Biochem. 68:383–424. 1999.
View Article : Google Scholar
|
|
30
|
Kuo PC, Liu HF and Chao JI: Survivin and
p53 modulate quercetin-induced cell growth inhibition and apoptosis
in human lung carcinoma cells. J Biol Chem. 279:55875–55885. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schuler M and Green DR: Mechanisms of
p53-dependent apoptosis. Biochem Soc Trans. 29:684–688. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shen Y and White E: p53-dependent
apoptosis pathways. Adv Cancer Res. 82:55–84. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
de la Iglesia N, Konopka G, Puram SV, Chan
JA, Bachoo RM, You MJ, Levy DE, Depinho RA and Bonni A:
Identification of a PTEN-regulated STAT3 brain tumor suppressor
pathway. Genes Dev. 22:449–462. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lewis HD, Winter A, Murphy TF, Tripathi S,
Pandey VN and Barton BE: STAT3 inhibition in prostate and
pancreatic cancer lines by STAT3 binding sequence oligonucleotides:
Differential activity between 5′ and 3′ ends. Mol Cancer Ther.
7:1543–1550. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kortylewski M, Jove R and Yu H: Targeting
STAT3 affects melanoma on multiple fronts. Cancer Metastasis Rev.
24:315–327. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Niu G, Bowman T, Huang M, Shivers S,
Reintgen D, Daud A, Chang A, Kraker A, Jove R and Yu H: Roles of
activated Src and Stat3 signaling in melanoma tumor cell growth.
Oncogene. 21:7001–7010. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xie TX, Huang FJ, Aldape KD, Kang SH, Liu
M, Gershenwald JE, Xie K, Sawaya R and Huang S: Activation of stat3
in human melanoma promotes brain metastasis. Cancer Res.
66:3188–3196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sellers LA, Feniuk W, Humphrey PP and
Lauder H: Activated G protein-coupled receptor induces tyrosine
phosphorylation of STAT3 and agonist-selective serine
phosphorylation via sustained stimulation of mitogen-activated
protein kinase. Resultant effects on cell proliferation. J Biol
Chem. 274:16423–16430. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Y, Turkson J, Carter-Su C, Smithgall
T, Levitzki A, Kraker A, Krolewski JJ, Medveczky P and Jove R:
Activation of Stat3 in v-Src-transformed fibroblasts requires
cooperation of Jak1 kinase activity. J Biol Chem. 275:24935–24944.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kotha A, Sekharam M, Cilenti L, Siddiquee
K, Khaled A, Zervos AS, Carter B, Turkson J and Jove R: Resveratrol
inhibits Src and Stat3 signaling and induces the apoptosis of
malignant cells containing activated Stat3 protein. Mol Cancer
Ther. 5:621–629. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Niu G, Wright KL, Huang M, Song L, Haura
E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, et al:
Constitutive Stat3 activity up-regulates VEGF expression and tumor
angiogenesis. Oncogene. 21:2000–2008. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Forsythe JA, Jiang BH, Iyer NV, Agani F,
Leung SW, Koos RD and Semenza GL: Activation of vascular
endothelial growth factor gene transcription by hypoxia-inducible
factor 1. Mol Cell Biol. 16:4604–4613. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tolaney SM and Krop IE: Mechanisms of
trastuzumab resistance in breast cancer. Anticancer Agents Med
Chem. 9:348–355. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Buzdar AU: Role of biologic therapy and
chemotherapy in hormone receptor- and HER2-positive breast cancer.
Ann Oncol. 20:993–999. 2009. View Article : Google Scholar : PubMed/NCBI
|
